CONMED Q1 sales $295.5M (+21.9% YoY); raises FY 2023 revenue and EPS guidance

CONMED Corp

2023-Q1 EPS reported $0.06 revenue$295,468,000

Sales $295.5M (+21.9% as reported; +25.1% constant currency); acquisitions contributed ~570 bps growth.
GAAP diluted EPS $0.06 (down 87.2% YoY); adjusted diluted EPS $0.66 (down 5.7% YoY).
Raises FY 2023 revenue guidance to $1.205B-$1.250B from $1.170B-$1.220B.
Raises FY 2023 adjusted EPS guidance to $3.30-$3.50 from $3.20-$3.45.
Adjusted EBITDA $51.2M (17.3% margin) vs $43.7M (18.0% margin) in Q1 2022.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

CONMED Corp reported the full year 2023 results: revenue between $1.205 billion and $1.250 billion, EPS in the range of $3.30 to $3.50. Guidance raised.

Period: the full year 2023
Revenue: between $1.205 billion and $1.250 billion
EPS: in the range of $3.30 to $3.50
Guidance: raised
Result: guidance update

Exact text from the filing

Based on the first quarter results, the Company is raising its revenue guidance for the full year 2023 and now expects revenue between $1.205 billion and $1.250 billion, compared to its prior guidance of between $1.170 billion and $1.220 billion.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

CONMED Corp reported the first quarter ended March 31, 2023 results: revenue $295.5 million, EPS $0.06.

Period: the first quarter ended March 31, 2023
Revenue: $295.5 million
EPS: $0.06
Result: reported results

Exact text from the filing

Florida, April 26, 2023 – CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2023. First Quarter 2023 Highlights · Sales of $295.5 million increased 21.9% year over year as reported and 25.1% in constant currency. Acquisitions contributed approximately 570 basis points of growth. · Domestic revenue increased 25.4%

View on SEC.gov

59 earnings releases filed in the last 30 days. Browse all earnings releases →

CONMED Corp filing history →

Source: SEC EDGAR

accession 0001174947-23-000616

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.